Karel Miettinen 1 , 8 , Lemeng Dong 2 , 8 , Nicolas Navrot 3 , 8 , Thomas Schneider 4 , 9 , Vincent Burlat 5 , Jacob Pollier 6 , Lotte Woittiez 4 , 10 , Sander van der Krol 2 , Raphaël Lugan 3 , Tina Ilc 3 , Robert Verpoorte 1 , Kirsi-Marja Oksman-Caldentey 7 , Enrico Martinoia 4 , Harro Bouwmeester 2 , Alain Goossens 6 , Johan Memelink b , 1 , Danièle Werck-Reichhart a , 3
07 April 2014
The (seco)iridoids and their derivatives, the monoterpenoid indole alkaloids (MIAs), form two large families of plant-derived bioactive compounds with a wide spectrum of high-value pharmacological and insect-repellent activities. Vinblastine and vincristine, MIAs used as anticancer drugs, are produced by Catharanthus roseus in extremely low levels, leading to high market prices and poor availability. Their biotechnological production is hampered by the fragmentary knowledge of their biosynthesis. Here we report the discovery of the last four missing steps of the (seco)iridoid biosynthesis pathway. Expression of the eight genes encoding this pathway, together with two genes boosting precursor formation and two downstream alkaloid biosynthesis genes, in an alternative plant host, allows the heterologous production of the complex MIA strictosidine. This confirms the functionality of all enzymes of the pathway and highlights their utility for synthetic biology programmes towards a sustainable biotechnological production of valuable (seco)iridoids and alkaloids with pharmaceutical and agricultural applications.
The (seco)iridoids and their monoterpenoid indole alkaloid (MIA) derivatives are plant-derived
compounds with pharmaceutical applications. Here, the authors identify the last four
missing steps of the (seco)iridoid pathway, which they reconstitute in an alternative
plant host to produce the complex MIA, strictosidine.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/